Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

XALKORI for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 269 adverse event reports in the FDA FAERS database where XALKORI was used for Lung neoplasm malignant.

Most Reported Side Effects for XALKORI

Side Effect Reports % Deaths Hosp.
Disease progression 125 23.4% 53 12
Death 90 16.8% 90 6
Lung neoplasm malignant 67 12.5% 27 8
Nausea 64 12.0% 5 4
Diarrhoea 43 8.0% 0 4
Fatigue 32 6.0% 2 2
Vomiting 29 5.4% 3 6
Constipation 27 5.1% 1 3
Oedema peripheral 27 5.1% 4 2
Off label use 26 4.9% 10 2
Decreased appetite 20 3.7% 1 2
Dizziness 18 3.4% 0 3
Pneumonia 18 3.4% 7 9
Neoplasm malignant 17 3.2% 1 0
Dysgeusia 15 2.8% 0 0

Other Indications for XALKORI

Non-small cell lung cancer (70) Neoplasm malignant (20) Lung cancer metastatic (12) Non-small cell lung cancer metastatic (10) Lung adenocarcinoma (6) Tracheal cancer (5)

Other Drugs Used for Lung neoplasm malignant

ERLOTINIB (9,207) OSIMERTINIB (4,754) NIVOLUMAB (4,197) PEMBROLIZUMAB (3,575) CARBOPLATIN (3,487) ALECTINIB (2,932) PEMETREXED (2,422) CRIZOTINIB (1,949) BEVACIZUMAB (1,810) PACLITAXEL (1,747)

Related Pages

XALKORI Full Profile All Lung neoplasm malignant Drugs XALKORI Demographics XALKORI Timeline